03/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

03/2024

Mar 8, 2024, 19:12 | Drugs
Naveen Pemmaraju: Rusfertide for patients with phlebotomy-dependent Polycythemia Vera (PV)
Naveen Pemmaraju posted on LinkedIn: ''Honored to share our brand new paper recently published in…
Mar 8, 2024, 19:07 | Blog
Kimryn Rathmell: New drug type in the kidney cancer space and the value of rare disease research
Kimryn Rathmell, Director of National Cancer Institute, shared on X/Twitter: "I’m excited to see that the…
Mar 8, 2024, 19:03 | Insight
Lea Monteran: TIGIT blockade with MDSC inhibition may be a novel and promising therapeutic strategy to treat bone metastasis
Lea Monteran, Ph.D. student at Tel Aviv University, shared on X/Twitter: "I am excited to…
Mar 8, 2024, 18:55 | Blog
Toufic Kachaamy: The Colon Cancer Coalition walk
Toufic Kachaamy, Chief of Medicine and Director of Gastroenterology at City of Hope, recently shared…
Mar 8, 2024, 15:42 | Blog
Razelle Kurzrock: 638 patients on nivo ipi show linear correlation between tumor size change and outcome
Razelle Kurzrock, Associate Director of Clinical Research for the Medical College of Wisconsin Cancer Center, shared…
Mar 8, 2024, 15:26 | Blog
Amol Akhade: The official statement issued by Tata Memorial Hospital regarding the recent social media discussion about research done by Professor Dr. Mitra and colleagues at TMH
Mar 8, 2024, 15:14 | Blog
Vivek Subbiah: Harnessing the potential of basket trials
Vivek Subbiah recently shared a post on X/Twitter: "Revolutionizing cancer drug development: Harnessing the potential…
Mar 8, 2024, 15:01 | Blog
Enrique Soto: The first publication from the Cancer Care MASCC Health Disparities Committee is out in Supportive Care in Cancer: Springer Journal!
Enrique Soto shared recently on X/Twitter: "The first publication from the Cancer Care MASCC Health…
Mar 8, 2024, 14:55 | Blog
Gabriel Revon-Riviere: Happy to share this work in collaboration with the amazing SickKids New Agents and Innovative Therapies (NAIT) team!
Gabriel Revon-Riviere, Pediatric Oncologist at the University Hospital of Marseille, shared a post on LinkedIn:…
Mar 8, 2024, 14:50 | Blog
Amalya Sargsyan: Incredible talk on Phase II trial designs by Dr. Mark Krailo during the Cancer Research Methods (Credo) Workshop in Lonavala, India
Amalya Sargsyan, Medical Oncologist at the Yeolyan Oncology and Hematology Center, shared a post on…
All: 860 Posts: 661 - 670
Special Coverage